Literature DB >> 23115299

Unstable polymerase-nucleoprotein interaction is not responsible for avian influenza virus polymerase restriction in human cells.

Anna V Cauldwell1, Olivier Moncorgé, Wendy S Barclay.   

Abstract

Avian-origin influenza virus polymerase activity can be dramatically increased in human cells with the PB2 E627K mutation. Previously, others have proposed that this mutation increases the stability of the viral ribonucleoprotein complex (vRNP) measured by the interaction between PB2 and NP. However, we demonstrate here that a variety of PB2 adaptive mutations, including E627K, do not enhance the stability of the vRNP but rather increase the amount of replicated RNA that results in more PB2-NP coprecipitation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115299      PMCID: PMC3554100          DOI: 10.1128/JVI.02597-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells.

Authors:  Karine Labadie; Emmanuel Dos Santos Afonso; Marie-Anne Rameix-Welti; Sylvie van der Werf; Nadia Naffakh
Journal:  Virology       Date:  2007-01-31       Impact factor: 3.616

2.  Mutational analysis of influenza virus promoter elements in vivo.

Authors:  G Neumann; G Hobom
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

3.  A single gene determines the host range of influenza virus.

Authors:  J W Almond
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

4.  The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host.

Authors:  G Gabriel; B Dauber; T Wolff; O Planz; H-D Klenk; J Stech
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

5.  Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses.

Authors:  N Naffakh; P Massin; N Escriou; B Crescenzo-Chaigne; S van der Werf
Journal:  J Gen Virol       Date:  2000-05       Impact factor: 3.891

6.  Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1.

Authors:  S K Biswas; D P Nayak
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Differential effect of nucleotide substitutions in the 3' arm of the influenza A virus vRNA promoter on transcription/replication by avian and human polymerase complexes is related to the nature of PB2 amino acid 627.

Authors:  Bernadette Crescenzo-Chaigne; Sylvie van der Werf; Nadia Naffakh
Journal:  Virology       Date:  2002-11-25       Impact factor: 3.616

8.  Replication of avian influenza viruses in humans.

Authors:  A S Beare; R G Webster
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range.

Authors:  E K Subbarao; W London; B R Murphy
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Genomic signatures of human versus avian influenza A viruses.

Authors:  Guang-Wu Chen; Shih-Cheng Chang; Chee-keng Mok; Yu-Luan Lo; Yu-Nong Kung; Ji-Hung Huang; Yun-Han Shih; Ji-Yi Wang; Chiayn Chiang; Chi-Jene Chen; Shin-Ru Shih
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

View more
  26 in total

1.  Influenza A virus polymerase is a site for adaptive changes during experimental evolution in bat cells.

Authors:  Daniel S Poole; Shuǐqìng Yú; Yíngyún Caì; Jorge M Dinis; Marcel A Müller; Ingo Jordan; Thomas C Friedrich; Jens H Kuhn; Andrew Mehle
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

2.  The RNA-dependent RNA polymerase of the influenza A virus.

Authors:  Thomas M Stubbs; Aartjan Jw Te Velthuis
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

3.  Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I.

Authors:  Michaela Weber; Hanna Sediri; Ulrike Felgenhauer; Ina Binzen; Sebastian Bänfer; Ralf Jacob; Linda Brunotte; Adolfo García-Sastre; Jonathan L Schmid-Burgk; Tobias Schmidt; Veit Hornung; Georg Kochs; Martin Schwemmle; Hans-Dieter Klenk; Friedemann Weber
Journal:  Cell Host Microbe       Date:  2015-02-19       Impact factor: 21.023

Review 4.  Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier.

Authors:  Benjamin Mänz; Martin Schwemmle; Linda Brunotte
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

5.  Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells.

Authors:  Shamika Danzy; Lydia R Studdard; Balaji Manicassamy; Alicia Solorzano; Nicolle Marshall; Adolfo García-Sastre; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

6.  Conserved features of the PB2 627 domain impact influenza virus polymerase function and replication.

Authors:  James Kirui; Michael D Bucci; Daniel S Poole; Andrew Mehle
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

7.  Differential Splicing of ANP32A in Birds Alters Its Ability to Stimulate RNA Synthesis by Restricted Influenza Polymerase.

Authors:  Steven F Baker; Mitchell P Ledwith; Andrew Mehle
Journal:  Cell Rep       Date:  2018-09-04       Impact factor: 9.423

8.  Multiple Natural Substitutions in Avian Influenza A Virus PB2 Facilitate Efficient Replication in Human Cells.

Authors:  Benjamin Mänz; Miranda de Graaf; Ramona Mögling; Mathilde Richard; Theo M Bestebroer; Guus F Rimmelzwaan; Ron A M Fouchier
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

Review 9.  Host and viral determinants of influenza A virus species specificity.

Authors:  Jason S Long; Bhakti Mistry; Stuart M Haslam; Wendy S Barclay
Journal:  Nat Rev Microbiol       Date:  2019-01       Impact factor: 60.633

10.  Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.

Authors:  Caroline Goujon; Olivier Moncorgé; Hélène Bauby; Tomas Doyle; Wendy S Barclay; Michael H Malim
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.